April 2026 in “Mendeley Data” April 2026 in “Mendeley Data”
3 citations
,
September 2019 in “Journal of The American Academy of Dermatology” In this correspondence, researchers reported that very-low-dose oral minoxidil (0.25 mg/d) showed some effectiveness in stabilizing trichoscopic parameters in male androgenetic alopecia. However, their analysis suggests that higher doses (2.5–5 mg/d) may lead to better clinical responses with similar rates of adverse events.
January 1987 in “Chronica Dermatologica” October 2025 in “Clinical and Experimental Dermatology” In this retrospective study, researchers reported that low-dose oral minoxidil significantly improved hair density in 60 patients with androgenetic alopecia or telogen effluvium over 4-8 months, as detected through standardized AI-powered imaging.